Tadalafil: Indications, Dosing, Contraindications, and Precautions
Tadalafil is FDA-approved for erectile dysfunction (ED) and benign prostatic hyperplasia (BPH), with dosing options including as-needed (5-20 mg) or once-daily (2.5-5 mg) regimens, but is absolutely contraindicated with any form of nitrate therapy. 1
Primary Indications
Erectile Dysfunction
Tadalafil is a first-line treatment option for ED and should be offered to all men with ED unless contraindicated 2. The medication works as a phosphodiesterase-5 (PDE5) inhibitor, enhancing vasodilation through the nitric oxide-cyclic GMP pathway.
Benign Prostatic Hyperplasia
Tadalafil 5 mg once daily is approved for BPH treatment and can be used for combined ED/BPH 1.
Off-Label Uses
- Peyronie's Disease: Daily tadalafil 5 mg demonstrated lower curvature progression rates and improved symptoms, and may help manage active-phase penile pain 3
- Premature Ejaculation: When combined with SSRIs, PDE5 inhibitors enhance confidence and sexual satisfaction, though they don't significantly improve intravaginal ejaculatory latency time alone 3
Dosing Regimens
For Erectile Dysfunction
As-Needed Dosing:
- Starting dose: 10 mg taken at least 30 minutes before sexual activity
- Dose range: 5-20 mg
- Maximum frequency: Once daily
- Efficacy window: Up to 36 hours 1
Once-Daily Dosing:
- Standard dose: 5 mg taken at approximately the same time daily
- Lower dose option: 2.5 mg daily
- No timing required relative to sexual activity 1
The choice between as-needed and daily dosing depends on sexual activity frequency. For men anticipating sexual activity at least twice weekly, once-daily dosing is preferred 4. Both regimens demonstrate similar efficacy, with success rates for intercourse attempts of 58-68% compared to 31% with placebo 5.
For Benign Prostatic Hyperplasia
- Dose: 5 mg once daily
- Timing: Same time each day, regardless of sexual activity 1
For Combined ED/BPH
- Dose: 5 mg once daily 1
Dose Adjustments
Renal Impairment
As-Needed Dosing:
- CrCl 30-50 mL/min: Start with 5 mg, maximum 10 mg once every 48 hours
- CrCl <30 mL/min or hemodialysis: Maximum 5 mg once every 72 hours 1
Once-Daily Dosing:
- CrCl <30 mL/min or hemodialysis: Not recommended for ED alone
- CrCl 30-50 mL/min for BPH/ED+BPH: Start 2.5 mg, may increase to 5 mg
- CrCl <30 mL/min for BPH/ED+BPH: Not recommended 1
Hepatic Impairment
Mild-Moderate (Child-Pugh A or B):
- As-needed: Maximum 10 mg once daily
- Once-daily: Use with caution 1
Severe (Child-Pugh C):
- Not recommended 1
Drug Interactions
With CYP3A4 Inhibitors (ketoconazole, ritonavir):
- As-needed: Maximum 10 mg once every 72 hours
- Once-daily: Maximum 2.5 mg 1
With Alpha-Blockers:
- For ED: Patient must be stable on alpha-blocker first, then start tadalafil at lowest dose
- For BPH: Combination not recommended 1
Absolute Contraindications
- Concurrent nitrate use in any form (including nitroglycerin, isosorbide mononitrate/dinitrate, recreational "poppers") 1
- Severe hepatic impairment (Child-Pugh C) 1
Critical Warnings and Precautions
Cardiovascular Considerations
ED itself is a risk marker for cardiovascular disease as strong as smoking or family history of MI 2. Before prescribing tadalafil, assess cardiovascular risk and communicate this to the patient and primary care provider. Patients should be counseled that sexual activity carries inherent cardiac risk.
Vision Loss (NAION)
Advise patients to stop tadalafil immediately and seek emergency care for sudden vision loss in one or both eyes 1. This may indicate non-arteritic anterior ischemic optic neuropathy, which can cause permanent vision loss. Risk is higher in patients with prior NAION in one eye or "crowded" optic disc.
Hearing Loss
Stop tadalafil and seek prompt medical attention for sudden hearing decrease or loss, which may be accompanied by tinnitus and dizziness 1.
Priapism
Patients must seek emergency care for erections lasting >4 hours (whether painful or not), as untreated priapism can cause irreversible erectile tissue damage 1.
Alcohol Interaction
Substantial alcohol consumption (≥5 units) combined with tadalafil increases risk of orthostatic hypotension, dizziness, increased heart rate, and headache due to additive vasodilatory effects 1.
Optimizing Efficacy
Proper patient instruction is essential for maximizing benefit 2:
- For as-needed dosing: Take at least 30 minutes before anticipated sexual activity
- Efficacy improves over the first several doses
- Can be taken without regard to food 1
- Dose titration should be performed to optimize response 2
Adverse Events
Most common side effects (dose-dependent):
- Headache
- Dyspepsia (lowest with avanafil among PDE5 inhibitors)
- Flushing (lowest with tadalafil)
- Back pain
- Nasal congestion
- Myalgia
- Visual disturbances
- Dizziness 2
Discontinuation rates are typically low, with adverse events generally mild-to-moderate 5.
Special Populations
Post-Prostatectomy
Men post-radical prostatectomy have more severe ED at baseline and respond less robustly to PDE5 inhibitors 2. Early use (within 45 days) has not been shown to improve unassisted erectile function for penile rehabilitation, though tadalafil remains effective for on-demand assistance.
Diabetes
Men with diabetes similarly have more severe baseline ED and reduced response compared to the general ED population 2.
Combination Therapy
For BPH with ED, combination tamsulosin plus tadalafil shows superior efficacy over tamsulosin alone for reducing lower urinary tract symptoms, improving quality of life, and enhancing erectile function, though with higher adverse event rates 6.
Emerging Evidence
Recent data suggests tadalafil may reduce risks of all-cause mortality (RR 0.66), myocardial infarction (RR 0.73), stroke (RR 0.66), and dementia (RR 0.68) in ED patients, with tadalafil showing more significant benefits than sildenafil 7. However, these observational findings require confirmation in prospective trials before influencing prescribing decisions.